{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AChE inhibitor", "Alzheimer's disease", "BACE1 inhibitor", "anti-amyloid inhibitor", "classical and non classical drug targets", "computational drug discovery", "multi-target-directed-ligands (MTDLs)."]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29542413", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "04"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "03"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1570159X16666180315141643"], "Journal": {"ISSN": "1875-6190", "JournalIssue": {"Volume": "16", "Issue": "6", "PubDate": {"Year": "2018"}}, "Title": "Current neuropharmacology", "ISOAbbreviation": "Curr Neuropharmacol"}, "ArticleTitle": "Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.", "Pagination": {"StartPage": "726", "EndPage": "739", "MedlinePgn": "726-739"}, "Abstract": {"AbstractText": ["Alzheimer disease (AD) is now considered as a multifactorial neurodegenerative disorder and rapidly increasing to an alarming situation and causing higher death rate. One target one ligand hypothesis does not provide complete solution of AD due to multifactorial nature of the disease and one target one drug fails to provide better treatment against AD. Moreover, currently available treatments are limited and most of the upcoming treatments under clinical trials are based on modulating single target. So, the current AD drug discovery research is shifting towards a new approach for a better solution that simultaneously modulates more than one targets in the neurodegenerative cascade. This can be achieved by network pharmacology, multi-modal therapies, multifaceted, and/or the more recently proposed term \"multi-targeted designed drugs\". Drug discovery project is a tedious, costly and long-term project. Moreover, multi-target AD drug discovery added extra challenges such as the good binding affinity of ligands for multiple targets, optimal ADME/T properties, no/less off-target side effect and crossing of the blood-brain barrier. These hurdles may be addressed by insilico methods for an efficient solution in less time and cost as computational methods successfully applied to single target drug discovery project. Here, we are summarizing some of the most prominent and computationally explored single targets against AD and further, we discussed a successful example of dual or multiple inhibitors for same targets. Moreover, we focused on ligand and structure-based computational approach to design MTDL against AD. However, it is not an easy task to balance dual activity in a single molecule but computational approach such as virtual screening docking, QSAR, simulation and free energy is useful in future MTDLs drug discovery alone or in combination with a fragment-based method. However, rational and logical implementations of computational drug designing methods are capable of assisting AD drug discovery and play an important role in optimizing multi-target drug discovery."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.org."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow-226015, (U.P.), India."}], "LastName": "Kumar", "ForeName": "Akhil", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow-226015, (U.P.), India."}], "LastName": "Tiwari", "ForeName": "Ashish", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow-226015, (U.P.), India."}], "LastName": "Sharma", "ForeName": "Ashok", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Neuropharmacol", "NlmUniqueID": "101157239", "ISSNLinking": "1570-159X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antipsychotic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antipsychotic Agents"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hippius H., Neund\u00f6rfer G. The discovery of Alzheimer\u2019s disease. Dialogues Clin. Neurosci. 2003;5(1):101\u2013108. [PMID: 22034141].", "ArticleIdList": ["PMC3181715", "22034141"]}, {"Citation": "Lautenschlager N.T., Martins R.N. Int. Psychogeriatr. IPA. 2005;17(Suppl. 1):S27\u2013S34. [http://dx.doi.org/10.1017/S1041610205002000].", "ArticleIdList": ["16240481"]}, {"Citation": "2016."}, {"Citation": "Jellinger K.A. General aspects of neurodegeneration. J. Neural Transm. Suppl. 2003;(65):101\u2013144. [http://dx.doi.org/10.1007/ 978-3-7091-0643-3_7]. [PMID: 12946052].", "ArticleIdList": ["12946052"]}, {"Citation": "Goedert M., Spillantini M.G. A century of Alzheimer\u2019s disease. Science. 2006;314(5800):777\u2013781. [http://dx.doi.org/10.1126/ science.1132814]. [PMID: 17082447].", "ArticleIdList": ["17082447"]}, {"Citation": "Karran E., Mercken M., De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 2011;10(9):698\u2013712. [http://dx.doi.org/10.1038/nrd3505]. [PMID: 21852788].", "ArticleIdList": ["21852788"]}, {"Citation": "Francis P., Palmer A., Snape M., Wilcock G. The cholinergic hypothesis of Alzheimer\u2019s Disease: A review of progress. J. Neurol. Neurosurg. Psychiatry. 1999;66(2):137\u2013147. [PMID: 10610396].", "ArticleIdList": ["PMC1736202", "10071091"]}, {"Citation": "Craig L.A., Hong N.S., McDonald R.J. Revisiting the cholinergic hypothesis in the development of Alzheimer\u2019s disease. Neurosci. Biobehav. Rev. 2011;35(6):1397\u20131409. [http://dx.doi.org/10. 1016/j.neubiorev.2011.03.001]. [PMID: 21392524].", "ArticleIdList": ["21392524"]}, {"Citation": "Bezprozvanny I., Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer\u2019s disease. Trends Neurosci. 2008;31(9):454\u2013463. [http://dx.doi.org/10.1016/j.tins.2008.06. 005]. [PMID: 18675468].", "ArticleIdList": ["PMC2566585", "18675468"]}, {"Citation": "Pratic\u00f2 D. Oxidative stress hypothesis in Alzheimer\u2019s disease: a reappraisal. Trends Pharmacol. Sci. 2008;29(12):609\u2013615. [http://dx.doi.org/10.1016/j.tips.2008.09.001]. [PMID: 18838179].", "ArticleIdList": ["18838179"]}, {"Citation": "Bonda D.J., Lee H., Blair J.A., Zhu X., Perry G., Smith M.A. Met. Integr. Biometal Sci. 2011;3(3):267\u2013270. [http://dx.doi.org/ 10.1039/c0mt00074d].", "ArticleIdList": ["PMC3117398", "21298161"]}, {"Citation": "Trepanier C.H., Milgram N.W. Neuroinflammation in Alzheimer\u2019s disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy? J. Alzheimers Dis. 2010;21(4):1089\u20131099. [http://dx.doi.org/10.3233/JAD-2010-090667]. [PMID: 21504126].", "ArticleIdList": ["21504126"]}, {"Citation": "Lle\u00f3 A., Greenberg S.M., Growdon J.H. Current pharmacotherapy for Alzheimer\u2019s disease. Annu. Rev. Med. 2006;57:513\u2013533. [http://dx.doi.org/10.1146/annurev.med.57.121304.131442]. [PMID: 16409164].", "ArticleIdList": ["16409164"]}, {"Citation": "Agis-Torres A., S\u00f6lhuber M., Fernandez M., Sanchez-Montero J.M. Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for alzheimer\u2019s disease. Curr. Neuropharmacol. 2014;12(1):2\u201336. [http://dx.doi.org/10.2174/ 1570159X113116660047]. [PMID: 24533013].", "ArticleIdList": ["PMC3915347", "24533013"]}, {"Citation": "Ono K., Hasegawa K., Naiki H., Yamada M. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro. Biochem. Biophys. Res. Commun. 2005;330(1):111\u2013116. [http://dx. doi.org/10.1016/j.bbrc.2005.02.132]. [PMID: 15781239].", "ArticleIdList": ["15781239"]}, {"Citation": "Vassar R. The beta-secretase, BACE: a prime drug target for Alzheimer\u2019s disease. J. Mol. Neurosci. 2001;17(2):157\u2013170. [http://dx.doi.org/10.1385/JMN:17:2:157]. [PMID: 11816789].", "ArticleIdList": ["11816789"]}, {"Citation": "Avram S., Milac A., Mihailescu D., Dabu A., Flonta M. Curr. Enzym. Inhib. 2006;2(4):311\u2013328. [http://dx.doi.org/10.2174/ 157340806778699307]."}, {"Citation": "Anand R., Gill K. D., Mahdi A. A. 2014."}, {"Citation": "Panza F., Solfrizzi V., Frisardi V., Capurso C., D\u2019Introno A., Colacicco A.M., Vendemiale G., Capurso A., Imbimbo B.P. Disease-modifying approach to the treatment of Alzheimer\u2019s disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging. 2009;26(7):537\u2013555. [http://dx. doi.org/10.2165/11315770-000000000-00000]. [PMID: 19655822].", "ArticleIdList": ["19655822"]}, {"Citation": "Tuppo E.E., Arias H.R. The role of inflammation in Alzheimer\u2019s disease. Int. J. Biochem. Cell Biol. 2005;37(2):289\u2013305. [http://dx.doi.org/10.1016/j.biocel.2004.07.009]. [PMID: 15474976].", "ArticleIdList": ["15474976"]}, {"Citation": "Fran\u00e7a M.B., Lima K.C., Eleutherio E.C.A. Oxidative stress and amyloid toxicity: insights from yeast. J. Cell. Biochem. 2017;118(6):1442\u20131452.", "ArticleIdList": ["27883213"]}, {"Citation": "Folch J., Petrov D., Ettcheto M., Abad S., S\u00e1nchez-L\u00f3pez E., Garc\u00eda M.L., Olloquequi J., Beas-Zarate C., Auladell C., Camins A. current research therapeutic strategies for alzheimer\u2019s disease treatment. Neural Plast. 2016;2016:8501693. [http://dx. doi.org/10.1155/2016/8501693]. [PMID: 26881137].", "ArticleIdList": ["PMC4735913", "26881137"]}, {"Citation": "Gallardo G., Holtzman D.M. Antibody therapeutics targeting A\u03b2 and Tau. Cold Spring Harb. Perspect. Med. 2017;7(10)", "ArticleIdList": ["PMC5500436", "28062555"]}, {"Citation": "Boutajangout A., Wisniewski T. Tau-based therapeutic approaches for Alzheimer\u2019s disease - a mini-review. Gerontology. 2014;60(5):381\u2013385. [http://dx.doi.org/10.1159/000358875]. [PMID: 24732638].", "ArticleIdList": ["PMC4149810", "24732638"]}, {"Citation": "Hamano T., Shirafuji N., Makino C., Yen S-H., Kanaan N.M., Ueno A., Suzuki J., Ikawa M., Matsunaga A., Yamamura O., Kuriyama M., Nakamoto Y. Pioglitazone prevents tau oligomerization. Biochem. Biophys. Res. Commun. 2016;478(3):1035\u20131042. [http://dx.doi.org/10.1016/j.bbrc.2016.08.016]. [PMID: 27543203].", "ArticleIdList": ["27543203"]}, {"Citation": "Llorens-Mart\u00edn M., Jurado J., Hern\u00e1ndez F., Avila J. GSK-3\u03b2, a pivotal kinase in Alzheimer disease. Front. Mol. Neurosci. 2014;7:46. [PMID: 24904272].", "ArticleIdList": ["PMC4033045", "24904272"]}, {"Citation": "Kang N.S., Lee G.N., Kim C.H., Bae M.A., Kim I., Cho Y.S. Identification of small molecules that inhibit GSK-3beta through virtual screening. Bioorg. Med. Chem. Lett. 2009;19(2):533\u2013537. [http://dx.doi.org/10.1016/j.bmcl.2008.10.120]. [PMID: 19081248].", "ArticleIdList": ["19081248"]}, {"Citation": "Sterling J., Herzig Y., Goren T., Finkelstein N., Lerner D., Goldenberg W., Miskolczi I., Molnar S., Rantal F., Tamas T., Toth G., Zagyva A., Zekany A., Finberg J., Lavian G., Gross A., Friedman R., Razin M., Huang W., Krais B., Chorev M., Youdim M.B., Weinstock M. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer\u2019s disease. J. Med. Chem. 2002;45(24):5260\u20135279. [http://dx.doi.org/10.1021/jm020120c]. [PMID: 12431053].", "ArticleIdList": ["12431053"]}, {"Citation": "Pisani L., Farina R., Soto-Otero R., Denora N., Mangiatordi G.F., Nicolotti O., Mendez-Alvarez E., Altomare C.D., Catto M., Carotti A. Searching for multi-targeting neurotherapeutics against alzheimer\u2019s: Discovery of potent AChE-MAO B inhibitors through the decoration of the 2H-chromen-2-one structural motif. Molecules. 2016;21(3):362. [http://dx.doi.org/10.3390/molecules 21030362]. [PMID: 26999091].", "ArticleIdList": ["PMC6273473", "26999091"]}, {"Citation": "Murray A.P., Faraoni M.B., Castro M.J., Alza N.P., Cavallaro V. Natural AChE Inhibitors from Plants and their Contribution to Alzheimer\u2019s Disease Therapy. Curr. Neuropharmacol. 2013;11(4):388\u2013413. [http://dx.doi.org/10.2174/1570159X11311040004]. [PMID: 24381530].", "ArticleIdList": ["PMC3744903", "24381530"]}, {"Citation": "Colovi\u0107 M.B., Krsti\u0107 D.Z., Lazarevi\u0107-Pa\u0161ti T.D., Bond\u017ei\u0107 A.M., Vasi\u0107 V.M. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr. Neuropharmacol. 2013;11(3):315\u2013335. [http:// dx.doi.org/10.2174/1570159X11311030006]. [PMID: 24179466].", "ArticleIdList": ["PMC3648782", "24179466"]}, {"Citation": "Khan M.T.H., Orhan I., Senol F.S., Kartal M., Sener B., Dvorsk\u00e1 M., Smejkal K., Slapetov\u00e1 T. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem. Biol. Interact. 2009;181(3):383\u2013389. [http://dx.doi.org/10.1016/j.cbi.2009.06.024]. [PMID: 19596285].", "ArticleIdList": ["19596285"]}, {"Citation": "Zhou A., Hu J., Wang L., Zhong G., Pan J., Wu Z., Hui A. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer\u2019s disease. J. Mol. Model. 2015;21(10):277. [http://dx.doi.org/10.1007/s00894-015-2797-8]. [PMID: 26438408].", "ArticleIdList": ["26438408"]}, {"Citation": "Vitorovi\u0107-Todorovi\u0107 M.D., Koukoulitsa C., Jurani\u0107 I.O., Mandi\u0107 L.M., Drakuli\u0107 B.J. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations. Eur. J. Med. Chem. 2014;81:158\u2013175. [http://dx.doi.org/10.1016/j. ejmech.2014.05.008]. [PMID: 24836068].", "ArticleIdList": ["24836068"]}, {"Citation": "Roy K.K., Tota S., Tripathi T., Chander S., Nath C., Saxena A.K. Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer\u2019s disease. Bioorg. Med. Chem. 2012;20(21):6313\u20136320. [http://dx.doi.org/10.1016/j.bmc.2012.09.005]. [PMID: 23026084].", "ArticleIdList": ["23026084"]}, {"Citation": "Basiri A., Murugaiyah V., Osman H., Kumar R.S., Kia Y., Ali M.A. Microwave assisted synthesis, cholinesterase enzymes inhibitory activities and molecular docking studies of new pyridopyrimidine derivatives. Bioorg. Med. Chem. 2013;21(11):3022\u20133031. [http://dx.doi.org/10.1016/j.bmc.2013.03.058]. [PMID: 23602518].", "ArticleIdList": ["23602518"]}, {"Citation": "Samadi A., Estrada M., P\u00e9rez C., Rodr\u00edguez-Franco M.I., Iriepa I., Moraleda I., Chioua M., Marco-Contelles J. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer\u2019s disease: synthesis, biological assessment, and molecular modeling. Eur. J. Med. Chem. 2012;57:296\u2013301. [http://dx. doi.org/10.1016/j.ejmech.2012.09.030]. [PMID: 23078965].", "ArticleIdList": ["23078965"]}, {"Citation": "Razavi S.F., Khoobi M., Nadri H., Sakhteman A., Moradi A., Emami S., Foroumadi A., Shafiee A. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Eur. J. Med. Chem. 2013;64:252\u2013259. [http://dx.doi.org/ 10.1016/j.ejmech.2013.03.021]. [PMID: 23644208].", "ArticleIdList": ["23644208"]}, {"Citation": "Kumar A., Nisha C.M., Silakari C., Sharma I., Anusha K., Gupta N., Nair P., Tripathi T., Kumar A. Current and novel therapeutic molecules and targets in Alzheimer\u2019s disease. J. Formos. Med. Assoc. 2016;115(1):3\u201310. [http://dx.doi.org/10.1016/ j.jfma.2015.04.001]. [PMID: 26220908].", "ArticleIdList": ["26220908"]}, {"Citation": "Varadaraju K.R., Kumar J.R., Mallesha L., Muruli A., Mohana K.N.S., Mukunda C.K., Sharanaiah U. Int. J. Alzheimers Dis. 2013;2013:e653962. [http://dx.doi.org/10.1155/2013/653962].", "ArticleIdList": ["PMC3830860", "24288651"]}, {"Citation": "Remya C., Dileep K.V., Tintu I., Variyar E.J., Sadasivan C. In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile. J. Mol. Model. 2013;19(3):1179\u20131194. [http://dx.doi.org/10.1007/s00894-012-1656-0]. [PMID: 23229229].", "ArticleIdList": ["23229229"]}, {"Citation": "Bar-On P., Millard C.B., Harel M., Dvir H., Enz A., Sussman J.L., Silman I. Biochemistry (Mosc.) 2002;41(11):3555\u20133564. [http://dx.doi.org/10.1021/bi020016x].", "ArticleIdList": ["11888271"]}, {"Citation": "Dvir H., Jiang H.L., Wong D.M., Harel M., Chetrit M., He X.C., Jin G.Y., Yu G.L., Tang X.C., Silman I., Bai D.L., Sussman J.L. Biochemistry (Mosc.) 2002;41(35):10810\u201310818. [http://dx.doi.org/10.1021/bi020151+].", "ArticleIdList": ["12196020"]}, {"Citation": "Hardy J.A., Higgins G.A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u2013185. [http://dx.doi. org/10.1126/science.1566067]. [PMID: 1566067].", "ArticleIdList": ["1566067"]}, {"Citation": "Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u2013356. [http://dx.doi.org/10.1126/science. 1072994]. [PMID: 12130773].", "ArticleIdList": ["12130773"]}, {"Citation": "Zeng H., Wu X. Alzheimer\u2019s disease drug development based on computer-aided drug design. Eur. J. Med. Chem. 2016;121:851\u2013863. [http://dx.doi.org/10.1016/j.ejmech.2015.08.039]. [PMID: 26415837].", "ArticleIdList": ["26415837"]}, {"Citation": "Chen D., Martin Z.S., Soto C., Schein C.H. Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. Bioorg. Med. Chem. 2009;17(14):5189\u20135197. [http://dx.doi.org/ 10.1016/j.bmc.2009.05.047]. [PMID: 19540126].", "ArticleIdList": ["PMC2743868", "19540126"]}, {"Citation": "Huy P.D.Q., Yu Y-C., Ngo S.T., Thao T.V., Chen C-P., Li M.S., Chen Y-C. In silico and in vitro characterization of anti-amyloidogenic activity of vitamin K3 analogues for Alzheimer\u2019s disease. Biochim. Biophys. Acta. 2013;1830(4):2960\u20132969. [http:// dx.doi.org/10.1016/j.bbagen.2012.12.026]. [PMID: 23295971].", "ArticleIdList": ["23295971"]}, {"Citation": "Lemkul J.A., Bevan D.R. Biochemistry (Mosc.) 2010;49(18):3935\u20133946. [http://dx.doi.org/10.1021/bi1000855].", "ArticleIdList": ["20369844"]}, {"Citation": "Berhanu W.M., Masunov A.E. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer. J. Biomol. Struct. Dyn. 2015;33(7):1399\u20131411. [http://dx.doi.org/10.1080/07391102.2014.951689]. [PMID: 25093402].", "ArticleIdList": ["25093402"]}, {"Citation": "Kumar A., Srivastava S., Tripathi S., Singh S.K., Srikrishna S., Sharma A. Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4\u2032 benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulations. J. Biomol. Struct. Dyn. 2016;34(6):1252\u20131263. [http:// dx.doi.org/10.1080/07391102.2015.1074943]. [PMID: 26208790].", "ArticleIdList": ["26208790"]}, {"Citation": "Zhang T., Zhang J., Derreumaux P., Mu Y. Molecular mechanism of the inhibition of EGCG on the Alzheimer A\u03b2(1-42) dimer. J. Phys. Chem. B. 2013;117(15):3993\u20134002. [http://dx.doi.org/ 10.1021/jp312573y]. [PMID: 23537203].", "ArticleIdList": ["23537203"]}, {"Citation": "Raman E.P., Takeda T., Klimov D.K. Molecular dynamics simulations of Ibuprofen binding to Abeta peptides. Biophys. J. 2009;97(7):2070\u20132079. [http://dx.doi.org/10.1016/j.bpj.2009.07.032]. [PMID: 19804739].", "ArticleIdList": ["PMC2756381", "19804739"]}, {"Citation": "Wu C., Wang Z., Lei H., Zhang W., Duan Y. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. J. Am. Chem. Soc. 2007;129(5):1225\u20131232. [http://dx.doi.org/10.1021/ja0662772]. [PMID: 17263405].", "ArticleIdList": ["17263405"]}, {"Citation": "Zhao J-H., Liu H-L., Elumalai P., Chen W-H., Men L-C., Liu K-T. Molecular modeling to investigate the binding of Congo red toward GNNQQNY protofibril and in silico virtual screening for the identification of new aggregation inhibitors. J. Mol. Model. 2013;19(1):151\u2013162. [http://dx.doi.org/10.1007/s00894-012-1532-y]. [PMID: 22836831].", "ArticleIdList": ["22836831"]}, {"Citation": "Rodr\u00edguez-Rodr\u00edguez C., Rimola A., Rodr\u00edguez-Santiago L., Ugliengo P., Alvarez-Larena A., Guti\u00e9rrez-de-Ter\u00e1n H., Sodupe M., Gonz\u00e1lez-Duarte P. Chem. Commun. Camb. Engl. 2010;46(7):1156\u20131158. [http://dx.doi.org/10.1039/b912396b].", "ArticleIdList": ["20126745"]}, {"Citation": "Fan H-M., Xu Q., Wei D-Q. 2017."}, {"Citation": "Eskici G., Gur M. Computational design of new Peptide inhibitors for amyloid Beta (a\u03b2) aggregation in Alzheimer\u2019s disease: application of a novel methodology. PLoS One. 2013;8(6):e66178. [http:// dx.doi.org/10.1371/journal.pone.0066178]. [PMID: 23762479].", "ArticleIdList": ["PMC3675214", "23762479"]}, {"Citation": "Yang Y., Cui M., Zhang X., Dai J., Zhang Z., Lin C., Guo Y., Liu B. Radioiodinated benzyloxybenzene derivatives: a class of flexible ligands target to \u03b2-amyloid plaques in Alzheimer\u2019s brains. J. Med. Chem. 2014;57(14):6030\u20136042. [http://dx.doi.org/ 10.1021/jm5004396]. [PMID: 24936678].", "ArticleIdList": ["24936678"]}, {"Citation": "Stoddard S.V., Hamann M.T., Wadkins R.M. Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-\u03b2 aggregation inhibitors. Mar. Drugs. 2014;12(4):2114\u20132131. [http://dx.doi.org/10.3390/md 12042114]. [PMID: 24714126].", "ArticleIdList": ["PMC4012451", "24714126"]}, {"Citation": "Lemkul J.A., Bevan D.R. The role of molecular simulations in the development of inhibitors of amyloid \u03b2-peptide aggregation for the treatment of Alzheimer\u2019s disease. ACS Chem. Neurosci. 2012;3(11):845\u2013856. [http://dx.doi.org/10.1021/cn300091a]. [PMID: 23173066].", "ArticleIdList": ["PMC3503341", "23173066"]}, {"Citation": "Lemkul J.A., Bevan D.R. Assessing the stability of Alzheimer\u2019s amyloid protofibrils using molecular dynamics. J. Phys. Chem. B. 2010;114(4):1652\u20131660. [http://dx.doi.org/10.1021/jp9110794]. [PMID: 20055378].", "ArticleIdList": ["20055378"]}, {"Citation": "Cole S.L., Vassar R. BACE1 structure and function in health and Alzheimer\u2019s disease. Curr. Alzheimer Res. 2008;5(2):100\u2013120. [http://dx.doi.org/10.2174/156720508783954758]. [PMID: 18393796].", "ArticleIdList": ["18393796"]}, {"Citation": "Huang W-H., Sheng R., Hu Y-Z. Progress in the development of nonpeptidomimetic BACE 1 inhibitors for Alzheimer\u2019s disease. Curr. Med. Chem. 2009;16(14):1806\u20131820. [http://dx.doi.org/ 10.2174/092986709788186174]. [PMID: 19442147].", "ArticleIdList": ["19442147"]}, {"Citation": "Huang D., L\u00fcthi U., Kolb P., Cecchini M., Barberis A., Caflisch A. In silico discovery of beta-secretase inhibitors. J. Am. Chem. Soc. 2006;128(16):5436\u20135443. [http://dx.doi.org/10.1021/ ja0573108]. [PMID: 16620115].", "ArticleIdList": ["16620115"]}, {"Citation": "Huang H-J., Lee C-C., Chen C.Y-C. BioMed Res. Int. 2014;2014:e741703."}, {"Citation": "Bajda M., Jo\u0144czyk J., Malawska B., Filipek S. Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling. Int. J. Mol. Sci. 2014;15(3):5128\u20135139. [http://dx.doi.org/10.3390/ijms15035128]. [PMID: 24663084].", "ArticleIdList": ["PMC3975444", "24663084"]}, {"Citation": "Dhanjal J.K., Goyal S., Sharma S., Hamid R., Grover A. Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer\u2019s plaque pathology. Biochem. Biophys. Res. Commun. 2014;443(3):1054\u20131059. [http:// dx.doi.org/10.1016/j.bbrc.2013.12.088]. [PMID: 24365147].", "ArticleIdList": ["24365147"]}, {"Citation": "Kumar A., Roy S., Tripathi S., Sharma A. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis. J. Biomol. Struct. Dyn. 2016;34(2):239\u2013249. [http://dx.doi.org/10.1080/07391102.2015.1022603]. [PMID: 25707809].", "ArticleIdList": ["25707809"]}, {"Citation": "Vijayan R.S.K., Prabu M., Mascarenhas N.M., Ghoshal N. Hybrid structure-based virtual screening protocol for the identification of novel BACE1 inhibitors. J. Chem. Inf. Model. 2009;49(3):647\u2013657. [http://dx.doi.org/10.1021/ci800386v]. [PMID: 19434899].", "ArticleIdList": ["19434899"]}, {"Citation": "Chiriano G., Sartini A., Mancini F., Andrisano V., Bolognesi M.L., Roberti M., Recanatini M., Carloni P., Cavalli A. Sequential virtual screening approach to the identification of small organic molecules as potential BACE-1 inhibitors. Chem. Biol. Drug Des. 2011;77(4):268\u2013271. [http://dx.doi.org/10.1111/j.1747-0285.2011. 01087.x]. [PMID: 21244641].", "ArticleIdList": ["21244641"]}, {"Citation": "Yi Mok N., Chadwick J., Kellett K.A.B., Hooper N.M., Johnson A.P., Fishwick C.W.G. Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening. Bioorg. Med. Chem. Lett. 2009;19(23):6770\u20136774. [http://dx.doi.org/10.1016/ j.bmcl.2009.09.103]. [PMID: 19854048].", "ArticleIdList": ["19854048"]}, {"Citation": "Xu W., Chen G., Liew O.W., Zuo Z., Jiang H., Zhu W. Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay. Bioorg. Med. Chem. Lett. 2009;19(12):3188\u20133192. [http://dx.doi.org/10.1016/j.bmcl.2009.04.113]. [PMID: 19447035].", "ArticleIdList": ["19447035"]}, {"Citation": "Murray C.W., Callaghan O., Chessari G., Cleasby A., Congreve M., Frederickson M., Hartshorn M.J., McMenamin R., Patel S., Wallis N. Application of fragment screening by X-ray crystallography to beta-secretase. J. Med. Chem. 2007;50(6):1116\u20131123. [http://dx.doi.org/10.1021/jm0611962]. [PMID: 17315856].", "ArticleIdList": ["17315856"]}, {"Citation": "Moitessier N., Therrien E., Hanessian S. A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors. J. Med. Chem. 2006;49(20):5885\u20135894. [http://dx.doi.org/10.1021/ jm050138y]. [PMID: 17004704].", "ArticleIdList": ["17004704"]}, {"Citation": "Koukoulitsa C., Villalonga-Barber C., Csonka R., Alexi X., Leonis G., Dellis D., Hamelink E., Belda O., Steele B.R., Micha-Screttas M., Alexis M.N., Papadopoulos M.G., Mavromoustakos T. Biological and computational evaluation of resveratrol inhibitors against Alzheimer\u2019s disease. J. Enzyme Inhib. Med. Chem. 2016;31(1):67\u201377. [http://dx.doi.org/10.3109/14756366. 2014.1003928]. [PMID: 26147348].", "ArticleIdList": ["26147348"]}, {"Citation": "Kacker P., Masetti M., Mangold M., Bottegoni G., Cavalli A. Combining dyad protonation and active site plasticity in BACE-1 structure-based drug design. J. Chem. Inf. Model. 2012;52(5):1079\u20131085. [http://dx.doi.org/10.1021/ci200366z]. [PMID: 22313091].", "ArticleIdList": ["22313091"]}, {"Citation": "Cosconati S., Marinelli L., Di Leva F.S., La Pietra V., De Simone A., Mancini F., Andrisano V., Novellino E., Goodsell D.S., Olson A.J. Protein flexibility in virtual screening: the BACE-1 case study. J. Chem. Inf. Model. 2012;52(10):2697\u20132704. [http:// dx.doi.org/10.1021/ci300390h]. [PMID: 23005250].", "ArticleIdList": ["PMC3523752", "23005250"]}, {"Citation": "Liu S., Fu R., Zhou L-H., Chen S-P. Application of consensus scoring and principal component analysis for virtual screening against \u03b2-secretase (BACE-1). PLoS One. 2012;7(6):e38086. [http://dx.doi.org/10.1371/journal.pone.0038086]. [PMID: 22701601].", "ArticleIdList": ["PMC3372491", "22701601"]}, {"Citation": "John S., Thangapandian S., Sakkiah S., Lee K.W. Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies. BMC Bioinformatics. 2011;12(Suppl. 1):S28. [http://dx.doi.org/10.1186/1471-2105-12-S1-S28]. [PMID: 21342558].", "ArticleIdList": ["PMC3044283", "21342558"]}, {"Citation": "Muthusamy K., Singh KhD., Chinnasamy S., Nagamani S., Krishnasamy G., Thiyagarajan C., Premkumar P., Anusuyadevi M. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors. Interdiscip. Sci. 2013;5(2):119\u2013126. [http://dx.doi.org/10.1007/s12539-013-0157-x]. [PMID: 23740393].", "ArticleIdList": ["23740393"]}, {"Citation": "Huang D., Liu Y., Shi B., Li Y., Wang G., Liang G. Comprehensive 3D-QSAR and binding mode of BACE-1 inhibitors using R-group search and molecular docking. J. Mol. Graph. Model. 2013;45:65\u201383. [http://dx.doi.org/10.1016/j.jmgm.2013.08.003]. [PMID: 24004830].", "ArticleIdList": ["24004830"]}, {"Citation": "Barman A., Sch\u00fcrer S., Prabhakar R. Biochemistry (Mosc.) 2011;50(20):4337\u20134349. [http://dx.doi.org/10.1021/bi200081h].", "ArticleIdList": ["21500768"]}, {"Citation": "Gueto-Tettay C., Zuchniarz J., Fortich-Seca Y., Gueto-Tettay L.R., Drosos-Ramirez J.C. A molecular dynamics study of the BACE1 conformational change from Apo to closed form induced by hydroxyethylamine derived compounds. J. Mol. Graph. Model. 2016;70:181\u2013195. [http://dx.doi.org/10.1016/j.jmgm.2016.10.006]. [PMID: 27750187].", "ArticleIdList": ["27750187"]}, {"Citation": "Gueto-Tettay C., Pestana-Nobles R., Drosos-Ramirez J.C. Determination of the protonation state for the catalytic dyad in \u03b2-secretase when bound to hydroxyethylamine transition state analogue inhibitors: A molecular dynamics simulation study. J. Mol. Graph. Model. 2016;66:155\u2013167. [http://dx.doi.org/10.1016/ j.jmgm.2016.04.003]. [PMID: 27111489].", "ArticleIdList": ["27111489"]}, {"Citation": "Xiong B., Huang X-Q., Shen L-L., Shen J-H., Luo X-M., Shen X., Jiang H-L., Chen K-X. Conformational flexibility of beta-secretase: molecular dynamics simulation and essential dynamics analysis. Acta Pharmacol. Sin. 2004;25(6):705\u2013713. [PMID: 15169620].", "ArticleIdList": ["15169620"]}, {"Citation": "Chakraborty S., Kumar S., Basu S. Conformational transition in the substrate binding domain of \u03b2-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study. Neurochem. Int. 2011;58(8):914\u2013923. [http://dx.doi.org/ 10.1016/j.neuint.2011.02.021]. [PMID: 21354237].", "ArticleIdList": ["21354237"]}, {"Citation": "Neri M., Cascella M., Micheletti C. J. Phys. Condens. Matter. 2005;17(18):S1581\u2013S1593. [http://dx.doi.org/10.1088/0953-8984/ 17/18/014]."}, {"Citation": "Holloway M.K., Hunt P., McGaughey G.B. Drug Dev. Res. 2009;70(2):70\u201393. [http://dx.doi.org/10.1002/ddr.20291]."}, {"Citation": "Rajamani R., Reynolds C.H. Modeling the protonation states of the catalytic aspartates in beta-secretase. J. Med. Chem. 2004;47(21):5159\u20135166. [http://dx.doi.org/10.1021/jm049817j]. [PMID: 15456259].", "ArticleIdList": ["15456259"]}, {"Citation": "Barman A., Prabhakar R. Protonation states of the catalytic dyad of \u03b2-secretase (BACE1) in the presence of chemically diverse inhibitors: a molecular docking study. J. Chem. Inf. Model. 2012;52(5):1275\u20131287. [http://dx.doi.org/10.1021/ci200611t]. [PMID: 22545704].", "ArticleIdList": ["22545704"]}, {"Citation": "Dom\u00ednguez J.L., Fern\u00e1ndez-Nieto F., Castro M., Catto M., Paleo M.R., Porto S., Sardina F.J., Brea J.M., Carotti A., Villaverde M.C., Sussman F. Computer-aided structure-based design of multitarget leads for Alzheimer\u2019s disease. J. Chem. Inf. Model. 2015;55(1):135\u2013148. [http://dx.doi.org/10.1021/ci500555g]. [PMID: 25483751].", "ArticleIdList": ["25483751"]}, {"Citation": "Butini S., Gabellieri E., Brindisi M., Casagni A., Guarino E., Huleatt P.B., Relitti N., La Pietra V., Marinelli L., Giustiniano M., Novellino E., Campiani G., Gemma S. Novel peptidomimetics as BACE-1 inhibitors: synthesis, molecular modeling, and biological studies. Bioorg. Med. Chem. Lett. 2013;23(1):85\u201389. [http://dx.doi.org/10.1016/j.bmcl.2012.11.011]. [PMID: 23218605].", "ArticleIdList": ["23218605"]}, {"Citation": "Truong A.P., T\u00f3th G., Probst G.D., Sealy J.M., Bowers S., Wone D.W.G., Dressen D., Hom R.K., Konradi A.W., Sham H.L., Wu J., Peterson B.T., Ruslim L., Bova M.P., Kholodenko D., Motter R.N., Bard F., Santiago P., Ni H., Chian D., Soriano F., Cole T., Brigham E.F., Wong K., Zmolek W., Goldbach E., Samant B., Chen L., Zhang H., Nakamura D.F., Quinn K.P., Yednock T.A., Sauer J-M. Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model. Bioorg. Med. Chem. Lett. 2010;20(21):6231\u20136236. [http:// dx.doi.org/10.1016/j.bmcl.2010.08.102]. [PMID: 20833041].", "ArticleIdList": ["20833041"]}, {"Citation": "Fukumoto H., Takahashi H., Tarui N., Matsui J., Tomita T., Hirode M., Sagayama M., Maeda R., Kawamoto M., Hirai K., Terauchi J., Sakura Y., Kakihana M., Kato K., Iwatsubo T., Miyamoto M. A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer\u2019s disease. J. Neurosci. 2010;30(33):11157\u201311166. [http://dx.doi.org/10.1523/JNEUROSCI.2884-10.2010]. [PMID: 20720123].", "ArticleIdList": ["PMC6633483", "20720123"]}, {"Citation": "Patel D.S., Bharatam P.V. New leads for selective GSK-3 inhibition: pharmacophore mapping and virtual screening studies. J. Comput. Aided Mol. Des. 2006;20(1):55\u201366. [http://dx.doi.org/10. 1007/s10822-006-9036-4]. [PMID: 16622795].", "ArticleIdList": ["16622795"]}, {"Citation": "Taha M.O., Bustanji Y., Al-Ghussein M.A.S., Mohammad M., Zalloum H., Al-Masri I.M., Atallah N. Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin. J. Med. Chem. 2008;51(7):2062\u20132077. [http://dx.doi.org/10.1021/ jm7009765]. [PMID: 18324764].", "ArticleIdList": ["18324764"]}, {"Citation": "Balakrishnan N., Raj J.S., Kandakatla N. Discovery of novel GSK-3\u03b2 inhibitors using pharmacophore and virtual screening studies. Interdiscip. Sci. 2016;8(3):303\u2013311. [http://dx.doi.org/ 10.1007/s12539-015-0100-4]. [PMID: 26298578].", "ArticleIdList": ["26298578"]}, {"Citation": "Kim H-J., Choo H., Cho Y.S., No K.T., Pae A.N. Novel GSK-3beta inhibitors from sequential virtual screening. Bioorg. Med. Chem. 2008;16(2):636\u2013643. [http://dx.doi.org/10.1016/j.bmc. 2007.10.047]. [PMID: 18006321].", "ArticleIdList": ["18006321"]}, {"Citation": "Khanfar M.A., Hill R.A., Kaddoumi A., El Sayed K.A. Discovery of novel GSK-3\u03b2 inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening. J. Med. Chem. 2010;53(24):8534\u20138545. [http://dx.doi.org/10.1021/jm100941j]. [PMID: 21082766].", "ArticleIdList": ["21082766"]}, {"Citation": "Polg\u00e1r T., Baki A., Szendrei G.I., Keseru G.M. Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3beta inhibitors. J. Med. Chem. 2005;48(25):7946\u20137959. [http://dx.doi.org/10.1021/jm050504d]. [PMID: 16335919].", "ArticleIdList": ["16335919"]}, {"Citation": "Vadivelan S., Sinha B.N., Tajne S., Jagarlapudi S.A.R.P. Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models. Eur. J. Med. Chem. 2009;44(6):2361\u20132371. [http://dx.doi.org/10.1016/j.ejmech.2008.08.012]. [PMID: 18929433].", "ArticleIdList": ["18929433"]}, {"Citation": "Joshi P., Gupta M., Vishwakarma R. A., Kumar A., Bharate S. B. 2016."}, {"Citation": "Natarajan P., Priyadarshini V., Pradhan D., Manne M., Swargam S., Kanipakam H., Bhuma V., Amineni U. E-pharmacophore-based virtual screening to identify GSK-3\u03b2 inhibitors. J. Recept. Signal Transduct. Res. 2016;36(5):445\u2013458. [http://dx.doi.org/10. 3109/10799893.2015.1122043]. [PMID: 27305963].", "ArticleIdList": ["27305963"]}, {"Citation": "Lin C-H., Hsieh Y-S., Wu Y-R., Hsu C-J., Chen H-C., Huang W-H., Chang K-H., Hsieh-Li H.M., Su M-T., Sun Y-C., Lee G-C., Lee-Chen G-J. Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci. 2016;89:11\u201319.", "ArticleIdList": ["27094783"]}, {"Citation": "Ombrato R., Cazzolla N., Mancini F., Mangano G. Structure-based discovery of 1H-indazole-3-carboxamides as a novel structural class of human GSK-3 inhibitors. J. Chem. Inf. Model. 2015;55(12):2540\u20132551. [http://dx.doi.org/10.1021/acs.jcim.5b00486]. [PMID: 26600430].", "ArticleIdList": ["26600430"]}, {"Citation": "Fu G., Sivaprakasam P., Dale O.R., Manly S.P., Cutler S.J., Doerksen R.J. Pharmacophore modeling, ensemble docking, virtual screening, and biological evaluation on glycogen synthase kinase-3\u03b2. Mol. Inform. 2014;33(9):610\u2013626. [http://dx.doi.org/ 10.1002/minf.201400044]. [PMID: 27486080].", "ArticleIdList": ["27486080"]}, {"Citation": "Fu G., Liu S., Nan X., Dale O.R., Zhao Z., Chen Y., Wilkins D.E., Manly S.P., Cutler S.J., Doerksen R.J. Quantitative structure-activity relationship analysis and a combined ligand-based/structure-based virtual screening study for glycogen synthase kinase-3. Mol. Inform. 2014;33(9):627\u2013640. [http://dx.doi.org/10. 1002/minf.201400045]. [PMID: 27486081].", "ArticleIdList": ["27486081"]}, {"Citation": "Patel D.S., Dessalew N., Iqbal P., Bharatam P.V. Structure-based approaches in the design of GSK-3 selective inhibitors. Curr. Protein Pept. Sci. 2007;8(4):352\u2013364. [http://dx.doi.org/10. 2174/138920307781369409]. [PMID: 17696868].", "ArticleIdList": ["17696868"]}, {"Citation": "Zhang P., Hu H-R., Huang Z-H., Lei J-Y., Chu Y., Ye D-Y. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3\u03b2 inhibitors through virtual screening. Bioorg. Med. Chem. Lett. 2012;22(23):7232\u20137236. [http://dx.doi.org/10.1016/j.bmcl.2012.09.043]. [PMID: 23099099].", "ArticleIdList": ["23099099"]}, {"Citation": "Schmitt B., Bernhardt T., Moeller H-J., Heuser I., Fr\u00f6lich L. Combination therapy in Alzheimer\u2019s disease: a review of current evidence. CNS Drugs. 2004;18(13):827\u2013844. [http://dx.doi.org/10. 2165/00023210-200418130-00001]. [PMID: 15521788].", "ArticleIdList": ["15521788"]}, {"Citation": "Cavalli A., Bolognesi M.L., Minarini A., Rosini M., Tumiatti V., Recanatini M., Melchiorre C. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 2008;51(3):347\u2013372. [http://dx.doi.org/10.1021/jm7009364]. [PMID: 18181565].", "ArticleIdList": ["18181565"]}, {"Citation": "Di Martino R.M.C., De Simone A., Andrisano V., Bisignano P., Bisi A., Gobbi S., Rampa A., Fato R., Bergamini C., Perez D.I., Martinez A., Bottegoni G., Cavalli A., Belluti F. Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3\u03b2 Inhibitors. J. Med. Chem. 2016;59(2):531\u2013544. [http://dx.doi.org/10.1021/acs.jmedchem.5b00894]. [PMID: 26696252].", "ArticleIdList": ["26696252"]}, {"Citation": "Malar D.S., Devi K.P. Dietary polyphenols for treatment of Alzheimer\u2019s disease--future research and development. Curr. Pharm. Biotechnol. 2014;15(4):330\u2013342. [http://dx.doi.org/10.2174/ 1389201015666140813122703]. [PMID: 25312617].", "ArticleIdList": ["25312617"]}, {"Citation": "De Ferrari G.V., Canales M.A., Shin I., Weiner L.M., Silman I., Inestrosa N.C. Biochemistry (Mosc.) 2001;40(35):10447\u201310457. [http://dx.doi.org/10.1021/bi0101392].", "ArticleIdList": ["11523986"]}, {"Citation": "Le\u00f3n R., Garcia A.G., Marco-Contelles J. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer\u2019s disease. Med. Res. Rev. 2013;33(1):139\u2013189. [http://dx. doi.org/10.1002/med.20248]. [PMID: 21793014].", "ArticleIdList": ["21793014"]}, {"Citation": "Piazzi L., Rampa A., Bisi A., Gobbi S., Belluti F., Cavalli A., Bartolini M., Andrisano V., Valenti P., Recanatini M. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer\u2019s disease therapy. J. Med. Chem. 2003;46(12):2279\u20132282. [http://dx.doi.org/10.1021/jm0340602]. [PMID: 12773032].", "ArticleIdList": ["12773032"]}, {"Citation": "Rosini M., Andrisano V., Bartolini M., Bolognesi M.L., Hrelia P., Minarini A., Tarozzi A., Melchiorre C. Rational approach to discover multipotent anti-Alzheimer drugs. J. Med. Chem. 2005;48(2):360\u2013363. [http://dx.doi.org/10.1021/jm049112h]. [PMID: 15658850].", "ArticleIdList": ["15658850"]}, {"Citation": "Rodr\u00edguez-Franco M.I., Fern\u00e1ndez-Bachiller M.I., P\u00e9rez C., Hern\u00e1ndez-Ledesma B., Bartolom\u00e9 B. Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties. J. Med. Chem. 2006;49(2):459\u2013462. [http://dx.doi.org/10.1021/jm050746d]. [PMID: 16420031].", "ArticleIdList": ["16420031"]}, {"Citation": "Bolognesi M.L., Cavalli A., Bergamini C., Fato R., Lenaz G., Rosini M., Bartolini M., Andrisano V., Melchiorre C. Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks. J. Med. Chem. 2009;52(23):7883\u20137886. [http://dx.doi.org/10.1021/jm901123n]. [PMID: 19813747].", "ArticleIdList": ["19813747"]}, {"Citation": "Bar-Am O., Weinreb O., Amit T., Youdim M.B.H. The novel cholinesterase-monoamine oxidase inhibitor and antioxidant, ladostigil, confers neuroprotection in neuroblastoma cells and aged rats. J. Mol. Neurosci. 2009;37(2):135\u2013145. [http://dx.doi.org/10. 1007/s12031-008-9139-6]. [PMID: 18751929].", "ArticleIdList": ["18751929"]}, {"Citation": "Marco-Contelles J., Unzeta M., Bolea I., Esteban G., Ramsay R.R., Romero A., Mart\u00ednez-Murillo R., Carreiras M.C., Ismaili L. ASS234, As a new multi-Target directed propargylamine for Alzheimer\u2019s disease therapy. Front. Neurosci. 2016;10:294.", "ArticleIdList": ["PMC4923252", "27445665"]}, {"Citation": "Piazzi L., Cavalli A., Colizzi F., Belluti F., Bartolini M., Mancini F., Recanatini M., Andrisano V., Rampa A. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. Bioorg. Med. Chem. Lett. 2008;18(1):423\u2013426. [http://dx.doi.org/10.1016/j.bmcl.2007.09. 100]. [PMID: 17998161].", "ArticleIdList": ["17998161"]}, {"Citation": "Zhu Y., Xiao K., Ma L., Xiong B., Fu Y., Yu H., Wang W., Wang X., Hu D., Peng H., Li J., Gong Q., Chai Q., Tang X., Zhang H., Li J., Shen J. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase. Bioorg. Med. Chem. 2009;17(4):1600\u20131613. [http://dx. doi.org/10.1016/j.bmc.2008.12.067]. [PMID: 19162488].", "ArticleIdList": ["19162488"]}, {"Citation": "Huang W., Tang L., Shi Y., Huang S., Xu L., Sheng R., Wu P., Li J., Zhou N., Hu Y. Searching for the Multi-Target-Directed Ligands against Alzheimer\u2019s disease: discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities. Bioorg. Med. Chem. 2011;19(23):7158\u20137167. [http://dx.doi.org/10.1016/j.bmc.2011.09.061]. [PMID: 22019465].", "ArticleIdList": ["22019465"]}, {"Citation": "Cavalli A., Bolognesi M.L., Capsoni S., Andrisano V., Bartolini M., Margotti E., Cattaneo A., Recanatini M., Melchiorre C. A small molecule targeting the multifactorial nature of Alzheimer\u2019s disease. Angew. Chem. Int. Ed. Engl. 2007;46(20):3689\u20133692. [http://dx.doi.org/10.1002/anie.200700256]. [PMID: 17397121].", "ArticleIdList": ["17397121"]}, {"Citation": "Huang W., Lv D., Yu H., Sheng R., Kim S.C., Wu P., Luo K., Li J., Hu Y. Dual-target-directed 1,3-diphenylurea derivatives: BACE 1 inhibitor and metal chelator against Alzheimer\u2019s disease. Bioorg. Med. Chem. 2010;18(15):5610\u20135615. [http://dx.doi.org/ 10.1016/j.bmc.2010.06.042]. [PMID: 20620068].", "ArticleIdList": ["20620068"]}, {"Citation": "Prati F., De Simone A., Armirotti A., Summa M., Pizzirani D., Scarpelli R., Bertozzi S.M., Perez D.I., Andrisano V., Perez-Castillo A., Monti B., Massenzio F., Polito L., Racchi M., Sabatino P., Bottegoni G., Martinez A., Cavalli A., Bolognesi M.L. 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3\u03b2 Fragment Hits against Alzheimer\u2019s Disease. ACS Chem. Neurosci. 2015;6(10):1665\u20131682. [http://dx.doi.org/10. 1021/acschemneuro.5b00121]. [PMID: 26171616].", "ArticleIdList": ["26171616"]}, {"Citation": "Morphy R., Rankovic Z. Designing multiple ligands - medicinal chemistry strategies and challenges. Curr. Pharm. Des. 2009;15(6):587\u2013600. [http://dx.doi.org/10.2174/138161209787315594]. [PMID: 19199984].", "ArticleIdList": ["19199984"]}, {"Citation": "Morphy R., Rankovic Z. The physicochemical challenges of designing multiple ligands. J. Med. Chem. 2006;49(16):4961\u20134970. [http://dx.doi.org/10.1021/jm0603015]. [PMID: 16884308].", "ArticleIdList": ["16884308"]}, {"Citation": "Bolognesi M.L., Melchiorre C., der Schyf C.J.V., Youdim M. 2012."}, {"Citation": "Bolognesi M.L., Rosini M., Andrisano V., Bartolini M., Minarini A., Tumiatti V., Melchiorre C. MTDL design strategy in the context of Alzheimer\u2019s disease: from lipocrine to memoquin and beyond. Curr. Pharm. Des. 2009;15(6):601\u2013613. [http://dx. doi.org/10.2174/138161209787315585]. [PMID: 19199985].", "ArticleIdList": ["19199985"]}, {"Citation": "Hughes R.E., Nikolic K., Ramsay R.R. One for all? Hitting multiple Alzheimer\u2019s Disease targets with one drug. Front. Neurosci. 2016;10:177. [http://dx.doi.org/10.3233/JAD-2008-14210]. [PMID: 18560133].", "ArticleIdList": ["PMC4842778", "27199640"]}, {"Citation": "Capurro V., Busquet P., Lopes J.P., Bertorelli R., Tarozzo G., Bolognesi M.L., Piomelli D., Reggiani A., Cavalli A. Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer\u2019s disease. PLoS One. 2013;8(2):e56870. [http://dx.doi.org/10.1371/journal.pone.0056870]. [PMID: 23441223].", "ArticleIdList": ["PMC3575497", "23441223"]}, {"Citation": "Pretorius J., Malan S.F., Castagnoli N., Jr, Bergh J.J., Petzer J.P. Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues. Bioorg. Med. Chem. 2008;16(18):8676\u20138684. [http://dx.doi.org/10.1016/j.bmc.2008.07.088]. [PMID: 18723354].", "ArticleIdList": ["18723354"]}, {"Citation": "Youdim M.B.H. Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline. Exp. Neurobiol. 2013;22(1):1\u201310. [http:// dx.doi.org/10.5607/en.2013.22.1.1]. [PMID: 23585716].", "ArticleIdList": ["PMC3620452", "23585716"]}, {"Citation": "Bautista-Aguilera O.M., Esteban G., Bolea I., Nikolic K., Agbaba D., Moraleda I., Iriepa I., Samadi A., Soriano E., Unzeta M., Marco-Contelles J. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer\u2019s disease. Eur. J. Med. Chem. 2014;75:82\u201395. [http://dx.doi.org/ 10.1016/j.ejmech.2013.12.028]. [PMID: 24530494].", "ArticleIdList": ["24530494"]}, {"Citation": "Bolea I., Ju\u00e1rez-Jim\u00e9nez J., de Los R\u00edos C., Chioua M., Pouplana R., Luque F.J., Unzeta M., Marco-Contelles J., Samadi A. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer\u2019s disease. J. Med. Chem. 2011;54(24):8251\u20138270. [http://dx.doi.org/10.1021/jm200853t]. [PMID: 22023459].", "ArticleIdList": ["22023459"]}, {"Citation": "Hughes R.E., Nikolic K., Ramsay R.R. Front. Neurosci. 2016;\u2022\u2022\u2022:10.", "ArticleIdList": ["PMC4842778", "27199640"]}, {"Citation": "Chen X., Decker M. Multi-target compounds acting in the central nervous system designed from natural products. Curr. Med. Chem. 2013;20(13):1673\u20131685. [http://dx.doi.org/10.2174/ 0929867311320130007]. [PMID: 23410166].", "ArticleIdList": ["23410166"]}, {"Citation": "Guzior N. ckowska, A. W.; Panek, D.; Malawska, B. Curr. Med. Chem. 2015;22(3):373\u2013404. [http://dx.doi.org/10.2174/ 0929867321666141106122628]. [PMID: 25386820].", "ArticleIdList": ["PMC4435057", "25386820"]}]}], "History": [{"Year": "2017", "Month": "1", "Day": "11"}, {"Year": "2017", "Month": "4", "Day": "1"}, {"Year": "2017", "Month": "5", "Day": "1"}, {"Year": "2018", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29542413", "PMC6080096", "10.2174/1570159X16666180315141643", "CN-EPUB-89132"]}}]}